Found: 69
Select item for more details and to access through your institution.
Oxidative stress-responsive apoptosis-inducing protein in patients with heterozygous familial hypercholesterolemia.
- Published in:
- Heart & Vessels, 2021, v. 36, n. 12, p. 1923, doi. 10.1007/s00380-021-01898-9
- By:
- Publication type:
- Article
An Interesting Case of Neonatal Atypical Hemolytic-Uremic Syndrome.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Older Familial Hypercholesterolemia Patients with COVID-19.
- Published in:
- Gerontology, 2021, v. 67, n. 5, p. 608, doi. 10.1159/000514447
- By:
- Publication type:
- Article
Evaluation of miRNA-27a/b expression in patients with familial hypercholesterolemia.
- Published in:
- Archives of Medical Science, 2024, v. 20, n. 4, p. 1314, doi. 10.5114/aoms/150500
- By:
- Publication type:
- Article
Treatment adherence and effect of concurrent statin intensity on the efficacy and safety of alirocumab in a real-life setting: results from ODYSSEY APPRISE.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Elevated Lipoprotein(a) and Its Implications for Familial Hypercholesterolemia Diagnosis, Prognosis, and Family Screening.
- Published in:
- Journal of Clinical Endocrinology & Metabolism, 2024, v. 109, n. 7, p. e1544, doi. 10.1210/clinem/dgad742
- By:
- Publication type:
- Article
Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14065, doi. 10.3390/ijms232214065
- By:
- Publication type:
- Article
Case report: Heterozygous Familial Hypercholesterolemia (HeFH).
- Published in:
- 2012
- By:
- Publication type:
- Case Study
Current causes of death in familial hypercholesterolemia.
- Published in:
- Lipids in Health & Disease, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12944-022-01671-5
- By:
- Publication type:
- Article
Long-term cancer risk in heterozygous familial hypercholesterolemia relatives: a 25-year cohort study.
- Published in:
- Lipids in Health & Disease, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12944-022-01666-2
- By:
- Publication type:
- Article
Coronary lesion complexity in patients with heterozygous familial hypercholesterolemia hospitalized for acute myocardial infarction: data from the RICO survey.
- Published in:
- Lipids in Health & Disease, 2021, v. 20, n. 1, p. 1, doi. 10.1186/s12944-021-01467-z
- By:
- Publication type:
- Article
Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia.
- Published in:
- 2021
- By:
- Publication type:
- journal article
A Rare Case of Bilateral Xanthelasma Palpebrarum in a 12-Year-Old Girl.
- Published in:
- Indian Journal of Paediatric Dermatology, 2023, v. 24, n. 2, p. 189, doi. 10.4103/ijpd.ijpd_46_22
- By:
- Publication type:
- Article
Case Series of Genetically Confirmed Index Cases of Familial Hypercholesterolemia in Primary Care.
- Published in:
- American Journal of Case Reports, 2023, v. 24, p. 1, doi. 10.12659/AJCR.939489
- By:
- Publication type:
- Article
Cholesterol lowering with inclisiran: a new chapter in the PCSK9 story book.
- Published in:
- European Heart Journal, 2023, v. 44, n. 2, p. 139, doi. 10.1093/eurheartj/ehac656
- By:
- Publication type:
- Article
Inclisiran in primary prevention: reality or fiction?
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 5058, doi. 10.1093/eurheartj/ehac653
- By:
- Publication type:
- Article
Underdiagnosis of familial hypercholesterolaemia: innovation is overdue.
- Published in:
- European Heart Journal, 2022, v. 43, n. 34, p. 3255, doi. 10.1093/eurheartj/ehab869
- By:
- Publication type:
- Article
Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
- Published in:
- European Heart Journal, 2021, v. 42, n. 32, p. 3063, doi. 10.1093/eurheartj/ehab424
- By:
- Publication type:
- Article
Inclisiran: A First-in-Class siRNA Therapy for Lowering Low-Density Lipoprotein Cholesterol.
- Published in:
- Annals of Pharmacotherapy, 2023, v. 57, n. 3, p. 317, doi. 10.1177/10600280221105169
- By:
- Publication type:
- Article
Monoclonal Anti-PCSK9 Antibodies: Real-World Data.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 15, p. 4543, doi. 10.3390/jcm13154543
- By:
- Publication type:
- Article
Risk Factors and Modifiers for Cardiovascular Disease Assessment of Patients with Heterozygous Familial Hypercholesterolaemia.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 8, p. 2270, doi. 10.3390/jcm13082270
- By:
- Publication type:
- Article
Metabolomic Approach to Screening Homozygotes in Chinese Patients with Severe Familial Hypercholesterolemia.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 2, p. 483, doi. 10.3390/jcm12020483
- By:
- Publication type:
- Article
Cardiovascular Risk Factors in Childhood and Adolescence.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 4, p. N.PAG, doi. 10.3390/jcm11041136
- By:
- Publication type:
- Article
Evaluation of Oxidative Stress Status in Familial Hypercholesterolemia.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 24, p. 5867, doi. 10.3390/jcm10245867
- By:
- Publication type:
- Article
Cataract Surgery in Elderly Subjects with Heterozygous Familial Hypercholesterolemia in Prolonged Treatment with Statins.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3494, doi. 10.3390/jcm10163494
- By:
- Publication type:
- Article
Impacto de un cribado oportunista de hipercolesterolemia familiar (estudio CRIBACOL) en el area sanitaria de Vigo.
- Published in:
- Galicia Clínica, 2022, v. 83, n. 3, p. 28, doi. 10.22546/66/2680
- By:
- Publication type:
- Article
Emerging Circulating Biomarkers in Atherosclerosis: From Molecular Mechanisms to Therapeutic Strategies.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 6, p. 809, doi. 10.3390/biom12060809
- By:
- Publication type:
- Article
PCSK9 Plasma Levels Are Associated with Mechanical Vascular Impairment in Familial Hypercholesterolemia Subjects without a History of Atherosclerotic Cardiovascular Disease: Results of Six-Month Add-On PCSK9 Inhibitor Therapy.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 4, p. 562, doi. 10.3390/biom12040562
- By:
- Publication type:
- Article
Still "on the Fence" About Universal Childhood Lipid Screening: The USPSTF Reaffirms an I Statement.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 3, p. 225, doi. 10.1001/jama.2023.11258
- By:
- Publication type:
- Article
Bempedoic Acid for High-Risk Primary Prevention of Cardiovascular Disease: Not a Statin Substitute but a Good Plan B.
- Published in:
- JAMA: Journal of the American Medical Association, 2023, v. 330, n. 2, p. 123, doi. 10.1001/jama.2023.9854
- By:
- Publication type:
- Article
Efficacy and safety of tafolecimab in Chinese patients with heterozygous familial hypercholesterolemia: a randomized, double-blind, placebo-controlled phase 3 trial (CREDIT-2).
- Published in:
- BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02797-8
- By:
- Publication type:
- Article
Endothelial Dysfunction, But Not Structural Atherosclerosis, Is Evident Early in Children With Heterozygous Familial Hypercholesterolemia.
- Published in:
- Pediatric Cardiology, 2014, v. 35, n. 1, p. 63, doi. 10.1007/s00246-013-0742-0
- By:
- Publication type:
- Article
An Eight-Week Trial Investigating the Efficacy and Tolerability of Atorvastatin for Children and Adolescents With Heterozygous Familial Hypercholesterolemia.
- Published in:
- Pediatric Cardiology, 2011, v. 32, n. 4, p. 433, doi. 10.1007/s00246-011-9885-z
- By:
- Publication type:
- Article
Systematic Review and Metaanalysis of Statins for Heterozygous Familial Hypercholesterolemia in Children: Evaluation of Cholesterol Changes and Side Effects.
- Published in:
- Pediatric Cardiology, 2009, v. 30, n. 4, p. 482, doi. 10.1007/s00246-008-9364-3
- By:
- Publication type:
- Article
Current concept and residual issues of lipoprotein(a) determination for a cardiovascular risk factor.
- Published in:
- European Journal of Clinical Investigation, 2022, v. 52, n. 1, p. 1, doi. 10.1111/eci.13700
- By:
- Publication type:
- Article
Effectiveness and safety of proprotein convertase subtilisin/kexin type 9 inhibitors in patients with familial hypercholesterolemia. Our experience in implementing the drug program of the Polish National Health Fund.
- Published in:
- Advances in Interventional Cardiology / Postępy w Kardiologii Interwencyjnej, 2022, v. 18, n. 2, p. 162, doi. 10.5114/aic.2022.118533
- By:
- Publication type:
- Article
Establishing non-fasting reference values for plasma lipids levels based on age, sex, and puberty stage in a French-Canadian pediatric population.
- Published in:
- Lipids in Health & Disease, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12944-024-02040-0
- By:
- Publication type:
- Article
Achilles tendon ultrasonography in familial hypercholesterolemia: A sub‐study of the LIpid transPort disorders Italian GEnetic Network (LIPIGEN).
- Published in:
- Journal of Internal Medicine, 2022, v. 291, n. 5, p. 702, doi. 10.1111/joim.13421
- By:
- Publication type:
- Article
МОНА ЛИЗА В НАШЕТО СЪВРЕМИЕ: ПАЦИЕНТ С ФАМИЛНА ХЕТЕРОЗИГОТНА ХИПЕРХОЛЕСТЕРОЛЕМИЯ.
- Published in:
- General Medicine / Obsta Medicina, 2022, v. 24, n. 4, p. 39
- By:
- Publication type:
- Article
МОНА ЛИЗА В НАШЕТО СЪВРЕМИЕ: ПАЦИЕНТ С ФАМИЛНА ХЕТЕРОЗИГОТНА ХИПЕРХОЛЕСТЕРОЛЕМИЯ.
- Published in:
- General Medicine / Obsta Medicina, 2022, v. 24, n. 4, p. 39
- By:
- Publication type:
- Article
Failure of lipid control by PCSK9 inhibitors in compound heterozygous familial hypercholesterolemia complicated with premature myocardial infarction: A case report.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Alirocumab: Pediatric First Approval.
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Familial Hypercholesterolemia: Screening, Diagnosis, and Treatment.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Heterozygous Familial Hyperlipidemia in a Fighter Pilot.
- Published in:
- Aerospace Medicine & Human Performance, 2021, v. 92, n. 10, p. 835, doi. 10.3357/AMHP.5906.2021
- By:
- Publication type:
- Article
High-density lipoprotein-associated sphingosine-1-phosphate activity in heterozygous familial hypercholesterolaemia.
- Published in:
- European Journal of Clinical Investigation, 2017, v. 47, n. 1, p. 38, doi. 10.1111/eci.12699
- By:
- Publication type:
- Article
Multimodal lipid-lowering treatment in pediatric patients with homozygous familial hypercholesterolemia—target attainment requires further increase of intensity.
- Published in:
- Pediatric Nephrology, 2018, v. 33, n. 7, p. 1199, doi. 10.1007/s00467-018-3906-6
- By:
- Publication type:
- Article
Cost-Effectiveness of Screening Strategies for Familial Hypercholesterolaemia: An Updated Systematic Review.
- Published in:
- PharmacoEconomics, 2024, v. 42, n. 4, p. 373, doi. 10.1007/s40273-023-01347-7
- By:
- Publication type:
- Article
Carotid and Aortic Stiffness in Patients with Heterozygous Familial Hypercholesterolemia.
- Published in:
- PLoS ONE, 2016, v. 11, n. 7, p. 1, doi. 10.1371/journal.pone.0158964
- By:
- Publication type:
- Article
Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.
- Published in:
- Cardiovascular Drugs & Therapy, 2024, v. 38, n. 1, p. 119, doi. 10.1007/s10557-022-07386-0
- By:
- Publication type:
- Article
A Comprehensive Review of PCSK9 Inhibitors.
- Published in:
- Journal of Cardiovascular Pharmacology & Therapeutics, 2022, v. 27, p. 1, doi. 10.1177/10742484221100107
- By:
- Publication type:
- Article